newsfilter
← Latest News
Business Wire·

Oligomerix Elects New Chairman William Caple to Board of Directors

Oligomerix, Inc., a privately held company pioneering the development of small molecule therapeutics targeting tau for rare neurodegenerative and Alzheimer's diseases, today announced the election of William Caple as